Kubes P, Smith R, Grisham M D, Granger D N
Department of Medical Physiology, University of Calgary, Alberta, Canada.
Inflammation. 1993 Jun;17(3):321-32. doi: 10.1007/BF00918993.
In this study, we assessed the underlying mechanisms by which proteinases released from activated neutrophils mediate fibronectin degradation. Purified human neutrophils (1 x 10(6)) were incubated for 1 hr with 1 microM PMA in the absence or presence of different proteinase inhibitors in 96-well microtiter plates that were coated with 125I-labeled fibronectin (FN). PMA-activated neutrophils caused 85% of FN to be degraded (versus 5% under control conditions). A selective inhibitor of elastase (L658,758), a monoclonal antibody directed against human neutrophilic elastase, and plasma all reduced the neutrophil-mediated FN degradation by 60%. A monoclonal antibody directed against the neutrophil adhesion glycoprotein CD11/CD18 increased the antiproteolytic effect of plasma to 70% but had no effect on the other anti-elastase agents, suggesting that the subjacent space formed by adherent neutrophils restricted to a small degree plasma derived antiproteinases. Agents that blocked cathepsin G or cathepsin G and elastase completely prevented the proteolysis associated with PMA-stimulated neutrophils, suggesting that the actions of elastase may be dependent on the presence of biologically active cathepsin G.
在本研究中,我们评估了活化的中性粒细胞释放的蛋白酶介导纤连蛋白降解的潜在机制。将纯化的人中性粒细胞(1×10⁶)与1μM佛波酯(PMA)在有无不同蛋白酶抑制剂的情况下于包被有¹²⁵I标记纤连蛋白(FN)的96孔微量滴定板中孵育1小时。PMA活化的中性粒细胞导致85%的FN被降解(而对照条件下为5%)。弹性蛋白酶的选择性抑制剂(L658,758)、针对人中性粒细胞弹性蛋白酶的单克隆抗体以及血浆均使中性粒细胞介导的FN降解减少60%。针对中性粒细胞黏附糖蛋白CD11/CD18的单克隆抗体将血浆的抗蛋白水解作用提高到70%,但对其他抗弹性蛋白酶药物无影响,这表明黏附的中性粒细胞形成的下层空间对血浆来源的抗蛋白酶有一定程度的限制。阻断组织蛋白酶G或同时阻断组织蛋白酶G和弹性蛋白酶的药物完全阻止了与PMA刺激的中性粒细胞相关的蛋白水解作用,这表明弹性蛋白酶的作用可能依赖于生物活性组织蛋白酶G的存在。